CymitQuimica logo

D-(+)-Phenyllactic acid

CAS:

Ref. 3D-FP08624

25g
212.00€
50g
357.00€
100g
529.00€
250g
756.00€
500g
1,104.00€
D-(+)-Phenyllactic acid
Biosynth

Product Information

Name:D-(+)-Phenyllactic acid
Synonyms:
  • (R)-2-Hydroxy-3-phenylpropionic acid(R)-3-Phenyllactic acid
Brand:Biosynth
Description:D-(+)-phenyllactic acid is a pharmaceutical drug that is used to catalyze the asymmetric synthesis of chiral compounds. It is an enantiomer of L-phenyllactic acid, and it has been shown to be effective in the treatment of patients with breast cancer. D-(+)-phenyllactic acid can also be used to catalyze the formation of taxol, a clinical drug which has been shown to inhibit tumor growth. D-(+)-phenyllactic acid binds to the active site of catalase, an enzyme that breaks down hydrogen peroxide in cells. The reaction mechanism for catalysis by D-(+)-phenyllactic acid is not well understood, but it may involve monocarboxylic acids such as formic or acetic acids.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:166.17 g/mol
Formula:C9H10O3
Purity:Min. 95%
Color/Form:White Powder
InChI:InChI=1S/C9H10O3/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8,10H,6H2,(H,11,12)/t8-/m1/s1
InChI key:InChIKey=VOXXWSYKYCBWHO-MRVPVSSYSA-N
SMILES:O=C(O)[C@H](O)Cc1ccccc1

Technical inquiry about: D-(+)-Phenyllactic acid

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.